For the year ending 2025-12-31, NUVL had $116,054K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -425,377 |
| Stock-based compensation expense | 86,502 |
| Net accretion on marketable securities | 11,107 |
| Change in fair value of related party revenue share liability | -55,220 |
| Other non-cash | -345 |
| Prepaid expenses and other current assets | 6,342 |
| Other assets | 10,508 |
| Accounts payable | 24,599 |
| Accrued expenses and other liabilities | 11,459 |
| Net cash used in operating activities | -275,209 |
| Purchases of marketable securities | 1,057,766 |
| Proceeds from maturities and sales of marketable securities | 933,689 |
| Net cash used in investing activities | -124,077 |
| Proceeds from issuance of common stock, net | 515,722 |
| Payments of equity issuance costs | 382 |
| Payments of insurance costs financed by a third-party | 0 |
| Net cash provided by financing activities | 515,340 |
| Net increase (decrease) in cash and cash equivalents | 116,054 |
| Cash and cash equivalents at beginning of period | 145,691 |
| Cash and cash equivalents at end of period | 261,745 |
Nuvalent, Inc. (NUVL)
Nuvalent, Inc. (NUVL)